Caseware UK (AP4) 2025.0.111 2025.0.111 2025-12-312025-12-3112025-01-01falsefalseNo description of principal activity1truetrueThe members have not required the company to obtain an audit in accordance with section 476 of the Companies Act 2006. 05961058 2025-01-01 2025-12-31 05961058 2024-01-01 2024-12-31 05961058 2025-12-31 05961058 2024-12-31 05961058 c:Director1 2025-01-01 2025-12-31 05961058 d:CurrentFinancialInstruments 2025-12-31 05961058 d:CurrentFinancialInstruments 2024-12-31 05961058 d:CurrentFinancialInstruments d:WithinOneYear 2025-12-31 05961058 d:CurrentFinancialInstruments d:WithinOneYear 2024-12-31 05961058 d:ShareCapital 2025-12-31 05961058 d:ShareCapital 2024-12-31 05961058 d:RetainedEarningsAccumulatedLosses 2025-12-31 05961058 d:RetainedEarningsAccumulatedLosses 2024-12-31 05961058 c:FRS102 2025-01-01 2025-12-31 05961058 c:AuditExempt-NoAccountantsReport 2025-01-01 2025-12-31 05961058 c:FullAccounts 2025-01-01 2025-12-31 05961058 c:PrivateLimitedCompanyLtd 2025-01-01 2025-12-31 05961058 e:PoundSterling 2025-01-01 2025-12-31 iso4217:GBP xbrli:pure
Company registration number: 05961058







UNAUDITED FINANCIAL STATEMENTS
FOR THE YEAR ENDED
31 DECEMBER 2025


SWISS STERIPLANT LIMITED




































 


SWISS STERIPLANT LIMITED
 



CONTENTS



Page
Statement of financial position
1
Notes to the financial statements
2


 


SWISS STERIPLANT LIMITED
REGISTERED NUMBER:05961058



STATEMENT OF FINANCIAL POSITION
AS AT 31 DECEMBER 2025

2025
2024
Note
£
£

  

  

Creditors: amounts falling due within one year
 4 
(39,143)
(37,208)

Net current liabilities
  
 
 
(39,143)
 
 
(37,208)

Total assets less current liabilities
  
(39,143)
(37,208)

  

Net liabilities
  
(39,143)
(37,208)


Capital and reserves
  

Called up share capital 
  
3
3

Profit and loss account
  
(39,146)
(37,211)

  
(39,143)
(37,208)


The director considers that the company is entitled to exemption from audit under section 477 of the Companies Act 2006 and members have not required the company to obtain an audit for the year in question in accordance with section 476 of the Companies Act 2006.

The director acknowledges his responsibilities for complying with the requirements of the Companies Act 2006 with respect to accounting records and the preparation of financial statements.

The financial statements have been prepared in accordance with the provisions applicable to companies subject to the small companies regime and in accordance with the provisions of FRS 102 Section 1A - small entities.

The financial statements have been delivered in accordance with the provisions applicable to companies subject to the small companies regime.

The company has opted not to file the statement of income and retained earnings in accordance with provisions applicable to companies subject to the small companies' regime.

The financial statements were approved and authorised for issue by the board and were signed on its behalf by: 




M. F. Unternaehrer
Director

Date: 21 September 2026


The notes on page 2 form part of these financial statements.

Page 1

 


SWISS STERIPLANT LIMITED
 


 
NOTES TO THE FINANCIAL STATEMENTS
FOR THE YEAR ENDED 31 DECEMBER 2025

1.


General information

Swiss Steriplant Limited is a private company, limited by shares, registered in England and Wales, registration number 5961058. The registered office and principal place of business is stated on the company information page.

2.Accounting policies

 
2.1

Basis of preparation of financial statements

The financial statements have been prepared under the historical cost convention unless otherwise specified within these accounting policies and in accordance with Financial Reporting Standard 102, the Financial Reporting Standard applicable in the UK and the Republic of Ireland and the Companies Act 2006. The disclosure requirements of Section 1A of FRS 102 have been applied other than where additional disclosure is required to show a true and fair view.

The following principal accounting policies have been applied:

 
2.2

Going concern

The director has pledged to provide continuing financial support to the company for the foreseeable future. For
this reason the director continues to adopt the going concern basis of accounting in preparing the annual financial statements.

  
2.3

Financial instruments

The company only enters into basic financial instrument transactions that result in the recognition of financial assets and liabilities like trade and other debtors and creditors, loans from banks and other third parties, loansto related parties and investments in ordinary shares.


3.


Employees

The average monthly number of employees, including directors, during the year was 1 (2024 -1).


4.


Creditors: Amounts falling due within one year

2025
2024
£
£

Other creditors
37,943
36,008

Accruals and deferred income
1,200
1,200

39,143
37,208



5.


Related party transactions

As at 31 December 2025, within other creditors there is a balance owed to the director of £37,943 (2024 - £36,008) by the company. The loan has been provided interest free and is repayable on demand.

 
Page 2